×
Cellectis S.A Income Taxes 2015-2025 | CLLS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Cellectis S.A income taxes from 2015 to 2025. Income taxes can be defined as the total amount of income tax expense for the given period.
View More
Cellectis S.A Income Taxes 2015-2025 | CLLS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Cellectis S.A income taxes from 2015 to 2025. Income taxes can be defined as the total amount of income tax expense for the given period.
Related Stocks
Company Name
Market
Cap
AstraZeneca (AZN)
$222.8B
Amgen (AMGN)
$162B
Gilead Sciences (GILD)
$140.6B
Vertex Pharmaceuticals (VRTX)
$118.3B
Bristol Myers Squibb (BMY)
$96.7B
CSL (CSLLY)
$85.2B
GSK (GSK)
$76.5B
Regeneron Pharmaceuticals (REGN)
$60.3B
Alnylam Pharmaceuticals (ALNY)
$42.3B
Argenex SE (ARGX)
$36.4B
BioNTech SE (BNTX)
$27.1B
Royalty Pharma (RPRX)
$20.8B
Insmed (INSM)
$19.3B
Biogen (BIIB)
$18.9B
Illumina (ILMN)
$17.4B
Genmab (GNMSF)
$15.2B
Genmab (GMAB)
$14.8B
Incyte (INCY)
$13.6B
Moderna (MRNA)
$13.1B
Exelixis (EXEL)
$12.1B
QIAGEN (QGEN)
$11.3B
BioMarin Pharmaceutical (BMRN)
$11.1B
Swedish Orphan Biovitrum (BIOVF)
$10.6B
Ascendis Pharma (ASND)
$10B
Bio-Techne Corp (TECH)
$9.2B
Exact Sciences (EXAS)
$9.1B
Verona Pharma American Depositary Share (VRNA)
$8.9B
Blueprint Medicines (BPMC)
$8.3B
Roivant Sciences (ROIV)
$7.7B
Legend Biotech (LEGN)
$7.6B